GSI HRV Pill - white capsule/oblong, 14mm
Generic Name: ledipasvir/sofosbuvir
Pill with imprint GSI HRV is White, Capsule/Oblong and has been identified as Harvoni ledipasvir 45 mg / sofosbuvir 200 mg.
Harvoni is used in the treatment of Hepatitis C and belongs to the drug class antiviral combinations. There is no proven risk in humans during pregnancy. Harvoni ledipasvir 45 mg / sofosbuvir 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for GSI HRV
Harvoni
- Generic Name
- ledipasvir/sofosbuvir
- Imprint
- GSI HRV
- Strength
- ledipasvir 45 mg / sofosbuvir 200 mg
- Color
- White
- Size
- 14.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiviral combinations
- Pregnancy Category
- B - No proven risk in humans
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Manufacturer
- Gilead Sciences
- National Drug Code (NDC)
- 61958-1803
See also:
Epclusa
Epclusa treats chronic hepatitis C in adults and children 3+. This once-daily antiviral combines ...
Mavyret
Mavyret (glecaprevir/pibrentasvir) is an oral combination medicine containing fixed doses of two ...
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Sovaldi
Sovaldi (sofosbuvir) is used to treat chronic hepatitis C virus (HCV) infection. Includes Sovaldi ...
Pegasys
Pegasys is used to treat chronic hepatitis B or C. Learn about side effects, interactions and ...
Vosevi
Vosevi (sofosbuvir,velpatasvir and voxilaprevir) is used to treat chronic hepatitis C. Includes ...
Zepatier
Zepatier (elbasvir and grazoprevir) is used to treat chronic hepatitis C. Includes Zepatier side ...
More about Harvoni (ledipasvir / sofosbuvir)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (403)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- FDA approval history
- Drug class: antiviral combinations
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.